ImpactConnecting European research communities and Australian universities directly to secure multi-lateral funding, lead commercial Work Packages, and execute global trial protocols

Bio-Runway
A clear path connecting clinical innovation in Europe with Australia’s life sciences ecosystem.
Cross-border potential needs more than an idea.
One Runway.
Many Horizons.
Your Choice.
We help make the journey between where you want to be and how you’re going to get there: strategically aligned, scientifically grounded and ready for action.


Clarity for
the next move.
The six pathways that connect the Bio-Runway to Europe and Australia.
ImpactDirect strategic alignment with the European Union Delegation to Australia and the Australian Government. Collaboration with the Queensland State Government and US West Coast innovation hubs to position Queensland as a global life sciences gateway.
ImpactAccelerating specialized biomanufacturing scale-up with CDMO partners, streamlining TGA/EU compliance, and navigating Australian health-care industry.
ImpactBuilding lasting institutional trust through transparent governance, public health alignment, and strategic policy engagement.
ImpactMobilizing Australian automotive culture, alongside state government leadership (DETSI) and diplomatic allies to drive high-visibility funding for cause partners (Cancer Council Australia, The University of Queensland MND Research Group, and MND and Me Foundation).
ImpactTranslating complex clinical data, research infrastructure, and healthcare advocacy into high-impact visual storytelling that gain attention across government, industry, and public domain platforms.

Why AusNordia Was Established
Science knows no borders, but clinical commercialization requires structured pathways, cultural alignment, and active community engagement to succeed.
Following her relocation from Finland to Queensland in 2022, Founder & Managing Director Hanna K. Kanti-Paul recognized a critical gap in the global life sciences ecosystem: biotechnology and clinical innovations frequently hit friction points when translating across international borders. These bottlenecks rarely arise from a deficit of science—they stem from a lack of execution infrastructure, complex regulatory frameworks, and cross-cultural misalignment.
“AusNordia was established to be the trusted Bio-runway where complex international science meets local execution, institutional trust, and commercial market access. We directly bridge critical gaps in cross-cultural alignment and rigorous data integrity—embedding European GDPR standards, ICH-GCP trial governance, and uncompromising compliance into every cross-border pipeline.
Grounded in 30+ years of European hospital diagnostics, Tier-1 MedTech leadership, and clinical trial governance, I bring high-level expertise to support the growth of Australian life sciences. Building on this global foundation, backed by 4.5 years of direct engagement within Australia’s healthcare architecture and university networks, AusNordia eliminates cross-border friction to speed up clinical translation and market entry.”
— Hanna K. Kanti-Paul, Founder & Managing Director
Read Hanna’s full bioFlagship Media Co-Creations
Video portfolio
Translational Infrastructure & Scientific Co-Creation
Scientific SponsorshipProduced in partnership with Prof. Derek Richard (Scientific Director, Cancer & Ageing Research Program - CARP at Queensland University of Technology - QUT).
OverviewHighlighting cutting-edge research infrastructure and scientific translation capability in Queensland.
Media ProductionHaZ2B Pty Ltd — Zoran Kanti-Paul
Cross-Sector Media & Parliamentary Engagement
CollaborationOrchestrated campaign uniting Queensland State Parliament representation (DETSI), The University of Queensland (UQ MND Research Group), and the MND and Me Foundation.
OverviewDemonstrating how non-traditional networks, executive diplomacy, and creative media drive major public health advocacy.
Media ProductionHaZ2B Pty Ltd — Zoran Kanti-Paul
Begin a conversation with AusNordia.
AusNordia
Hanna K. Kanti-Paul, MHML, BBMedSc
Founder & Managing Director